The CASE-J trial enrolled 4728 patients, with a mean age of 63.8 years and a mean BMI of 24.6 kg/m 2, who were randomly assigned to either candesartan- or amlodipine ... mg/dl or higher, HbA 1c of ...

Armed with new data, GSK is preparing to file for approval of its new-generation meningitis vaccine, as it tries to maintain its leadership in the category against a challenge from Pfizer.

AbbVie said on Friday that the U.S. Food and Drug Administration approved its drug for complicated intra-abdominal infections ...

Pfizer reported fourth-quarter earnings and revenue that beat estimates as sales of the company's Covid products came in higher than expected and cancer drugs from Seagen boosted revenue.

COVID products are still a profit driver for the company. Pfizer is forecast by Wall Street to report $5.3 billion in 2024 sales of its COVID antiviral treatment Paxlovid. They are expected to ...

Pfizer and BioNTech have announced that they have submitted an Emergency Use Authorisation (EUA) to the US Food and Drug Administration (FDA) for their Omicron BA.4/BA.5-adapted bivalent COVID-19 ...

Other potential PAM agents without class 1 data include levetiracetam, zonisamide, cyproheptadine, verapamil, amlodipine ... mg/24 h, 6 mg/week) Migranal® nasal spray 4 mg/ml nasal spray One ...

for every 5 shares held Bonus--Bonus Ratio: 1 share(s) for every 2 shares held Pfizer Ltd., incorporated in the year 1950, is a Large Cap company (having a market cap of Rs 20,247.03 Crore) operating ...

News and insight from the business world.

Ugo Monye, Chris Jones and Danny Care cover the biggest rugby union stories of the week.

After hours: 7:59:45 pm GMT-5 ...